Location: San Diego, CA
CIK: 0001232621 · Show all filings
Period: Q4 2018 (← Previous) (Next →)
Filing Date: Feb 14, 2019
Total Value: $436M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | ODONATE THERAPEUTICS INC | 14,047,250 | $198M | 45.4% | $24.20 | — | COM | 676079106 |
| HRTX | HERON THERAPEUTICS INC | 5,818,541 | $151M | 34.6% | $14.10 | +95.0% | COM | 427746102 |
| RCKT | ROCKET PHARMACEUTICALS INC | 2,965,485 | $43.95M | 10.1% | $16.31 | +1.8% | COM | 77313F106 |
| — | LA JOLLA PHARMACEUTICAL CO | 3,878,893 | $36.58M | 8.4% | $18.53 | — | COM | 503459604 |
| PBYI | PUMA BIOTECHNOLOGY INC | 247,400 | $5.035M | 1.2% | $30.01 | 0.0% | COM | 74587V107 |
| — | OPHTHOTECH CORP | 600,000 | $720K | 0.2% | $1.20 | — | COM | 683745103 |
| PRTA | PROTHENA CORP PLC | 47,610 | $490K | 0.1% | $11.89 | 0.0% | SHS | G72800108 |
| EQ | EQUILLIUM INC | 47,343 | $386K | 0.1% | $13.90 | 0.0% | COM | 29446K106 |